Respiratory Syncytial Virus Vaccines for the Prevention of Lower Respiratory Tract Infections in Patients Living with Chronic Obstructive Pulmonary Disease: A Rapid Review

Background: Patients living with chronic obstructive pulmonary disease (COPD) are at risk for lower respiratory tract infections caused by respiratory syncytial virus (RSV). The first RSV vaccines were approved in 2023 for adults ages 60 years and older. The safety and efficacy of the RSV vaccines a...

Description complète

Détails bibliographiques

Auteurs principaux:	Paul M. Boylan, Megan E. Fleischman, Nathan Pinner, Joseph Andrew Woods, Adam Welch
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2024-01-01
Collection:	Biologics
Sujets:	respiratory syncytial virus vaccines respiratory syncytial virus respiratory tract infections chronic obstructive pulmonary disease
Accès en ligne:	https://www.mdpi.com/2673-8449/4/1/2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!